| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |